Stay updated on PRINCE Trial: PSMA-lutetium & Immunotherapy in Prostate Cancer
Sign up to get notified when there's something new on the PRINCE Trial: PSMA-lutetium & Immunotherapy in Prostate Cancer page.

Latest updates to the PRINCE Trial: PSMA-lutetium & Immunotherapy in Prostate Cancer page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe page now displays revision v3.6.6, replacing the previous v3.6.5. This indicates a minor update to the page’s content or structure without altering the study information.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedRevision: v3.6.5 was added and Revision: v3.6.4 was removed, updating the page's revision number. This reflects the current version of the page in the footer metadata.SummaryDifference0.1%

- Check46 days agoChange DetectedThe page now shows revision v3.6.4, replacing the previous v3.6.3. This appears to be a software maintenance update rather than a modification to study content.SummaryDifference0.1%

- Check68 days agoChange DetectedThe page now shows Revision: v3.6.3, replacing the previous v3.6.2. This indicates a minor update to the page version or metadata rather than substantive content changes.SummaryDifference0.1%

- Check75 days agoChange DetectedThe page shows Revision: v3.6.2 instead of v3.6.0, reflecting an update to the site's underlying software version.SummaryDifference0.1%

- Check89 days agoChange DetectedRecruitment status on the study page was updated to indicate no longer seeking participants, reflecting that enrollment has ended. The page also gained new help and navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and updated the Intervention/Treatment heading formatting to align with the new layout.SummaryDifference0.5%

Stay in the know with updates to PRINCE Trial: PSMA-lutetium & Immunotherapy in Prostate Cancer
Enter your email address, and we'll notify you when there's something new on the PRINCE Trial: PSMA-lutetium & Immunotherapy in Prostate Cancer page.